FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
批准号:
10464756
负责人:
Alex Toker
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-05-31
关键词:
AreaBiochemicalBiochemistryBiological ProcessBiologyCanadaCareer MobilityCellular biologyChemicalsClinicalCollaborationsCommunicationDataDevelopmentDiabetes MellitusDiagnosisDisciplineDiseaseDisease modelDrug IndustryDrug TargetingEducational workshopEventFDA approvedFacultyFertilizationFosteringFundingFutureGoalsGrowth and Development functionHealthHumanInflammationInflammatoryIslandKnowledgeLightingLinkMalignant NeoplasmsMediatingMedicineMentorsMetabolic DiseasesMetabolic syndromeMethodologyMethodsMiningMolecularNormal CellNova ScotiaOncologyPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPlayPreventionPrincipal InvestigatorProcessProtein EngineeringProtein KinaseProtein Kinase Protein PhosphorylationProtein phosphataseProteomeReportingResearchResearch PersonnelRoleScienceScientistSenior ScientistSignal TransductionSiteStructureStructure-Activity RelationshipStudentsSystemSystems BiologyTechnologyTimeTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsWomancareercareer developmentforgingfrontierhuman diseaseimprovedin vivo Modelinnovationinsightinterestkinase inhibitormeetingsminority scientistmultidisciplinarynext generationnovelnovel anticancer drugnovel therapeuticspostersprogramsrecruitsocialstructural biologysummer researchsymposiumtherapeutic developmenttherapeutic target
中文摘要
方案主任/首席调查员(最后、第一、中间):Toker,A./Bennett,A.
蛋白质磷酸化在分子通信中至关重要,分子通信控制细胞状态和
活动。这是一个由正常人群中精确调控的激酶和磷酸酶介导的动态过程。
在许多人类疾病中,包括糖尿病、炎症性疾病和癌症,都是去调节的。这项研究
蛋白质磷酸化机制及其在信号系统中的功能是一个非常活跃的领域
推动了方法学和概念进步的研究,并越来越多地为
治疗方案的发展。蛋白激酶在癌症中经常被解除调控,它们一直是
这是制药业最近强烈兴趣的焦点。事实上,大多数新的抗癌药物都是由
FDA在过去的几年里针对的是激酶,目前有数百种新的激酶抑制剂正在研发中。
发展。这种强大的临床联系提供了与翻译科学的令人兴奋的联系。
在这项申请中,我们申请资金以支持学员、初级教员和传统的
在2022年FASEB关于蛋白激酶和蛋白质的夏季研究会议上代表不足的群体
磷酸化。这一两年一度的会议始于1983年,是一次重要的跨学科会议,
将具有不同专业知识的科学家聚集在一起,以促进对生化机制和
磷酸化事件的基本原则-这是本次会议与其他会议的不同之处
使用信令网络和系统方法。这次FASE B会议一直是,并将继续是主要的
为宣布该领域的突破提供了场所,并有一个长期目标要加强,以及
传播将导致针对异常激酶活性和蛋白质的改进治疗的知识
磷酸化,在人类疾病中。2022年FASEB关于蛋白激酶和蛋白质的科学研究会议
蛋白质磷酸化旨在突出蛋白质磷酸化领域的最新前沿发现,以
将结构生物学、生物化学、系统生物学、化学生物学、蛋白质工程和
医药。这将促进这些通常独立的学科之间的交叉受精,以刺激新的系列
以及加强不同科学家的交流、合作和职业发展
在战场上。最终目标是推动该领域的发展,以更好地理解分子机制。
调节重要的生物过程,并有助于确定诊断的关键目标,
人类疾病的预防、治疗和治愈。
OMB编号0925-0001/0002(01/18修订版批准至2020年3月31日)页面续格式页面
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Toker, A./Bennett, A.
Protein phosphorylation is vitally important in the molecular communications that control cellular state and
activity. It is a dynamic process mediated by kinases and phosphatases that are precisely regulated in normal
cells, and deregulated in many human diseases, including diabetes, inflammatory disease and cancer. The study
of the protein phosphorylation machinery and its function in signaling systems is a robustly active area of
research that has driven methodological and conceptual advances and is increasingly contributing to the
development of therapeutic options. Protein kinases are frequently deregulated in cancer, and they have been
the focus of intense recent interest by the pharmaceutical industry. Indeed, most new cancer drugs approved by
the FDA in the last several years target kinases, and there are hundreds of new kinase inhibitors under
development. This strong clinical connection provides an exciting link with translational science.
In this application, we request funds to support attendance of trainees, junior faculty and traditionally
underrepresented groups at the 2022 FASEB Summer Research conference on Protein Kinases and Protein
Phosphorylation. This biennial conference started in 1983, and is an important interdisciplinary gathering that
brings together scientists with diverse expertise to advance understanding of the biochemical mechanisms and
fundamental principles of phosphorylation events – a focus that distinguishes this meeting from others that deal
with signaling networks and systems approaches. This FASEB meeting has been, and continues to be, a primary
venue for the announcement of breakthroughs in the field, and has a long-standing goal to enhance, and
disseminate, knowledge that will lead to improved therapies to target aberrant kinase activity, and protein
phosphorylation, in human disease. The 2022 FASEB Science Research Conference on Protein Kinases and
Protein Phosphorylation aims to highlight recent, cutting-edge findings in the field of protein phosphorylation, to
bring together structural biology, biochemistry, systems biology, chemical biology, protein engineering, and
medicine. This will promote cross-fertilization among these normally separate disciplines to stimulate new lines
of research, as well as to enhance communication, collaboration, career advancement for the diverse scientists
in the field. The ultimate goal is to advance the field to obtain better understandings of the molecular mechanisms
that regulate important biological processes and facilitate the identification of critical targets for the diagnosis,
prevention, treatment, and cure of human diseases.
OMB No. 0925-0001/0002 (Rev. 01/18 Approved Through 03/31/2020) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10246864
-
项目类别:
-
资助金额:$103.5万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10677761
-
项目类别:
-
资助金额:$97.51万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10471296
-
项目类别:
-
资助金额:$100.84万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9903255
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9270532
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Identifying lincRNAs that Mediate PI 3 Kinase Dependent Breast Cancer
-
批准号:8610428
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2014
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:9812868
-
项目类别:
-
资助金额:$41.56万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8870311
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8559337
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8702122
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
FASEB Summer Research Conference on Lipid Signaling Pathways in Cancer
-
批准号:7329084
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:8024499
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7256658
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7579113
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7388910
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7772392
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6604523
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6910034
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of NFAT and NFAT-Induced Genes in Carcinoma
-
批准号:8055453
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6505993
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
海外基金